Oxycodone Drug Market Size, Share, Trends, Growth Outlook

The Global Oxycodone Drug Market Size is estimated to register 5.2% growth over the forecast period from 2024 to 2030.

 

The market growth is driven by an increasing rise of telehealth services has facilitated greater access to pain management therapies, including oxycodone prescriptions, especially in underserved areas or during public health crises. Telemedicine platforms allow healthcare providers to conduct remote consultations, monitor patient progress, and prescribe medications like oxycodone when clinically appropriate. This trend is driven by factors such as convenience, cost-effectiveness, and the need for alternative healthcare delivery models. Leading Companies focusing on the Development of Targeted Therapies, Personalized Medicine Approaches, Integration of Digital Health Solutions, and others to boost market shares in the industry.

 

Oxycodone Drug Market Overview

The oxycodone drug market, historically significant for managing moderate to severe pain, faces challenges amidst stricter regulations and public health concerns surrounding opioid misuse. Innovations like abuse-deterrent formulations (ADFs) aim to deter abuse, yet market growth is tempered by regulatory pressures and competition. Consolidation among pharmaceutical companies reshapes the competitive landscape, while heightened awareness of opioid risks drives advocacy for evidence-based pain management. The market's evolution hinges on balancing therapeutic needs with mitigating risks, navigating regulatory complexities, and exploring safer prescribing practices amid changing public health priorities.

 

Oxycodone Drug Market Dynamics

Oxycodone Drug Market Trends- From Pharmaceutical darling to public enemy, exploring the industry's role in its rise and fall

This piece investigates the intricate story of the opioid crisis, tracing the evolution of opioids from heralded pain relief breakthroughs to symbols of a significant public health crisis. It delves into the influential role the pharmaceutical industry has played in the widespread availability of opioid medications, analyzing marketing tactics, regulatory gaps, and the ethical dimensions of opioid manufacturing and distribution. By drawing on expert opinions and real-life examples, the article seeks to illuminate the diverse factors contributing to the opioid crisis and stimulate essential conversations about the industry's accountability in confronting this urgent public health challenge.

Market Driver- The rise of alternative pain management therapies is challenging the oxycodone drug market.

The rise in popularity of alternative pain management methods poses a significant challenge to the oxycodone drug market, which has traditionally been dominated by opioid medications. This piece investigates how emerging therapies like acupuncture, physical therapy, and non-opioid pharmacological treatments are impacting the demand for oxycodone. Through an analysis of market trends, regulatory changes, and consumer preferences, we delve into the factors behind this disruption and its implications for pharmaceutical firms, healthcare providers, and patients. We also discuss strategies for adapting to this changing landscape, such as diversifying product portfolios and investing in research and development of non-opioid alternatives, to address the pressing public health need to reduce opioid dependence and misuse.

Market Opportunity- Researchers are developing new treatments specifically designed to address the oxycodone drug market.

Researchers are actively pursuing the development of innovative treatments tailored to address the unique challenges within the oxycodone drug market. This involves exploring alternative pain management therapies that provide effective relief while reducing the potential for addiction and abuse commonly associated with traditional opioids such as oxycodone. Moreover, there's a concerted focus on creating targeted therapies and personalized medicine strategies, leveraging advancements in pharmacogenomics and data analytics to tailor treatment plans to individual patients. Additionally, researchers are delving into cutting-edge drug delivery technologies and formulations, including abuse-deterrent formulations (ADFs), aimed at improving the safety and efficacy of oxycodone medications. These research initiatives underscore a proactive approach to meeting the evolving needs and concerns of patients, healthcare providers, and regulatory agencies in the oxycodone drug market, with the overarching goal of enhancing patient outcomes and mitigating the risks associated with opioid use.

Market Share Analysis- Long-acting Oxycodone Drug Market will register the fastest growth

The Global Oxycodone Drug Market is analyzed across Short-acting, Long-acting, and others. Long-acting is poised to register the fastest growth. The long-acting oxycodone drug market encompasses extended-release formulations of oxycodone designed to provide prolonged pain relief, primarily for chronic conditions. Growth in this market is driven by increasing demand for sustained pain management, advancements in drug delivery technologies, and efforts to improve patient adherence. However, challenges such as opioid misuse and regulatory scrutiny persist, necessitating ongoing adaptation to changing healthcare landscapes and market dynamics.

Market Share Analysis- Hospital Pharmacies held a significant market share in 2024

The Global Oxycodone Drug Market is analyzed across various Distribution Channels including Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and others. Of these, Hospital Pharmacies held a significant market share in 2024. Hospital pharmacies are integral to the oxycodone drug market, efficiently supplying medications to patients in healthcare settings. They adhere to regulatory guidelines, prioritize patient safety, and collaborate with healthcare providers to optimize treatment outcomes and mitigate opioid-related risks.

 

Oxycodone Drug Market Segmentation

By Product Type

• Short-acting
• Long-acting

 

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

 

By Region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)

 

Oxycodone Drug Market Companies

• Sun Pharmaceutical Industries Ltd
• Collegium Pharmaceutical Inc
• Endo Pharmaceuticals Inc.
• Teva Pharmaceutical Industries Ltd
• Mallinckrodt Pharmaceuticals
• Akrimax Pharmaceuticals LLC
• Amneal Pharmaceuticals Inc
• Zyla Life Sciences (Egalet Corporation)
• Purdue Pharma LP
• Mundipharma Pty Limited

 

*List not exhaustive

Oxycodone Drug Market Outlook 2024

1 Market Overview

1.1 Introduction to the Oxycodone Drug Market

1.2 Scope of the Study

1.3 Research Objective

1.3.1 Key Market Scope and Segments

1.3.2 Players Covered

1.3.3 Years Considered

 

2 Executive Summary

2.1 2024 Oxycodone Drug Industry- Market Statistics

3 Market Dynamics

3.1 Market Drivers

3.2 Market Challenges

3.3 Market Opportunities

3.4 Market Trends

 

4 Market Factor Analysis

4.1 Porter’s Five Forces

4.2 Market Entropy

4.2.1 Global Oxycodone Drug Market Companies with Area Served

4.2.2 Products Offerings Global Oxycodone Drug Market

 

5 Recession Impact Analysis and Outlook Scenarios

5.1.1 Recission Impact Analysis

5.1.2 Market Growth Scenario- Base Case

5.1.3 Market Growth Scenario- Reference Case

5.1.4 Market Growth Scenario- High Case

 

6 Global Oxycodone Drug Market Trends

6.1 Global Oxycodone Drug Revenue (USD Million) and CAGR (%) by Type (2018-2032)

6.2 Global Oxycodone Drug Revenue (USD Million) and CAGR (%) by Applications (2018-2032)

6.3 Global Oxycodone Drug Revenue (USD Million) and CAGR (%) by regions (2018-2032)

 

7 Global Oxycodone Drug Market Revenue (USD Million) by Type, and Applications (2018-2023)

7.1 Global Oxycodone Drug Revenue (USD Million) by Type (2018-2023)

7.1.1 Global Oxycodone Drug Revenue (USD Million), Market Share (%) by Type (2018-2023)

7.2 Global Oxycodone Drug Revenue (USD Million) by Applications (2018-2023)

7.2.1 Global Oxycodone Drug Revenue (USD Million), Market Share (%) by Applications (2018-2023)

 

8 Global Oxycodone Drug Development Regional Status and Outlook

8.1 Global Oxycodone Drug Revenue (USD Million) By Regions (2018-2023)

8.2 North America Oxycodone Drug Revenue (USD Million) by Type, and Application (2018-2023)

8.2.1 North America Oxycodone Drug Revenue (USD Million) by Country (2018-2023)

8.2.2 North America Oxycodone Drug Revenue (USD Million) by Type (2018-2023)

8.2.3 North America Oxycodone Drug Revenue (USD Million) by Applications (2018-2023)

8.3 Europe Oxycodone Drug Revenue (USD Million), by Type, and Applications (USD Million) (2018-2023)

8.3.1 Europe Oxycodone Drug Revenue (USD Million), by Country (2018-2023)

8.3.2 Europe Oxycodone Drug Revenue (USD Million) by Type (2018-2023)

8.3.3 Europe Oxycodone Drug Revenue (USD Million) by Applications (2018-2023)

8.4 Asia Pacific Oxycodone Drug Revenue (USD Million), and Revenue (USD Million) by Type, and Applications (2018-2023)

8.4.1 Asia Pacific Oxycodone Drug Revenue (USD Million) by Country (2018-2023)

8.4.2 Asia Pacific Oxycodone Drug Revenue (USD Million) by Type (2018-2023)

8.4.3 Asia Pacific Oxycodone Drug Revenue (USD Million) by Applications (2018-2023)

8.5 South America Oxycodone Drug Revenue (USD Million), by Type, and Applications (2018-2023)

8.5.1 South America Oxycodone Drug Revenue (USD Million), by Country (2018-2023)

8.5.2 South America Oxycodone Drug Revenue (USD Million) by Type (2018-2023)

8.5.3 South America Oxycodone Drug Revenue (USD Million) by Applications (2018-2023)

8.6 Middle East and Africa Oxycodone Drug Revenue (USD Million), by Type, Technology, Application, Thickness (2018-2023)

8.6.1 Middle East and Africa Oxycodone Drug Revenue (USD Million) by Country (2018-2023)

8.6.2 Middle East and Africa Oxycodone Drug Revenue (USD Million) by Type (2018-2023)

8.6.3 Middle East and Africa Oxycodone Drug Revenue (USD Million) by Applications (2018-2023)

 

9 Company Profiles

 

10 Global Oxycodone Drug Market Revenue (USD Million), by Type, and Applications (2024-2032)

10.1 Global Oxycodone Drug Revenue (USD Million) and Market Share (%) by Type (2024-2032)

10.1.1 Global Oxycodone Drug Revenue (USD Million), and Market Share (%) by Type (2024-2032)

10.2 Global Oxycodone Drug Revenue (USD Million) and Market Share (%) by Applications (2024-2032)

10.2.1 Global Oxycodone Drug Revenue (USD Million), and Market Share (%) by Applications (2024-2032)

 

11 Global Oxycodone Drug Development Regional Status and Outlook Forecast

11.1 Global Oxycodone Drug Revenue (USD Million) By Regions (2024-2032)

11.2 North America Oxycodone Drug Revenue (USD Million) by Type, and Applications (2024-2032)

11.2.1 North America Oxycodone Drug Revenue (USD) Million by Country (2024-2032)

11.2.2 North America Oxycodone Drug Revenue (USD Million), by Type (2024-2032)

11.2.3 North America Oxycodone Drug Revenue (USD Million), Market Share (%) by Applications (2024-2032)

11.3 Europe Oxycodone Drug Revenue (USD Million), by Type, and Applications (2024-2032)

11.3.1 Europe Oxycodone Drug Revenue (USD Million), by Country (2024-2032)

11.3.2 Europe Oxycodone Drug Revenue (USD Million), by Type (2024-2032)

11.3.3 Europe Oxycodone Drug Revenue (USD Million), by Applications (2024-2032)

11.4 Asia Pacific Oxycodone Drug Revenue (USD Million) by Type, and Applications (2024-2032)

11.4.1 Asia Pacific Oxycodone Drug Revenue (USD Million), by Country (2024-2032)

11.4.2 Asia Pacific Oxycodone Drug Revenue (USD Million), by Type (2024-2032)

11.4.3 Asia Pacific Oxycodone Drug Revenue (USD Million), by Applications (2024-2032)

11.5 South America Oxycodone Drug Revenue (USD Million), by Type, and Applications (2024-2032)

11.5.1 South America Oxycodone Drug Revenue (USD Million), by Country (2024-2032)

11.5.2 South America Oxycodone Drug Revenue (USD Million), by Type (2024-2032)

11.5.3 South America Oxycodone Drug Revenue (USD Million), by Applications (2024-2032)

11.6 Middle East and Africa Oxycodone Drug Revenue (USD Million), by Type, and Applications (2024-2032)

11.6.1 Middle East and Africa Oxycodone Drug Revenue (USD Million), by region (2024-2032)

11.6.2 Middle East and Africa Oxycodone Drug Revenue (USD Million), by Type (2024-2032)

11.6.3 Middle East and Africa Oxycodone Drug Revenue (USD Million), by Applications (2024-2032)

 

12 Methodology and Data Sources

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Sources

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Disclaimer

 

List of Tables

Table 1 Market Segmentation Analysis

Table 2 Global Oxycodone Drug Market Companies with Areas Served

Table 3 Products Offerings Global Oxycodone Drug Market

Table 4 Low Growth Scenario Forecasts

Table 5 Reference Case Growth Scenario

Table 6 High Growth Case Scenario

Table 7 Global Oxycodone Drug Revenue (USD Million) And CAGR (%) By Type (2018-2032)

Table 8 Global Oxycodone Drug Revenue (USD Million) And CAGR (%) By Applications (2018-2032)

Table 9 Global Oxycodone Drug Revenue (USD Million) And CAGR (%) By Regions (2018-2032)

Table 10 Global Oxycodone Drug Revenue (USD Million) By Type (2018-2023)

Table 11 Global Oxycodone Drug Revenue Market Share (%) By Type (2018-2023)

Table 12 Global Oxycodone Drug Revenue (USD Million) By Applications (2018-2023)

Table 13 Global Oxycodone Drug Revenue Market Share (%) By Applications (2018-2023)

Table 14 Global Oxycodone Drug Market Revenue (USD Million) By Regions (2018-2023)

Table 15 Global Oxycodone Drug Market Share (%) By Regions (2018-2023)

Table 16 North America Oxycodone Drug Revenue (USD Million) By Country (2018-2023)

Table 17 North America Oxycodone Drug Revenue (USD Million) By Type (2018-2023)

Table 18 North America Oxycodone Drug Revenue (USD Million) By Applications (2018-2023)

Table 19 Europe Oxycodone Drug Revenue (USD Million) By Country (2018-2023)

Table 20 Europe Oxycodone Drug Revenue (USD Million) By Type (2018-2023)

Table 21 Europe Oxycodone Drug Revenue (USD Million) By Applications (2018-2023)

Table 22 Asia Pacific Oxycodone Drug Revenue (USD Million) By Country (2018-2023)

Table 23 Asia Pacific Oxycodone Drug Revenue (USD Million) By Type (2018-2023)

Table 24 Asia Pacific Oxycodone Drug Revenue (USD Million) By Applications (2018-2023)

Table 25 South America Oxycodone Drug Revenue (USD Million) By Country (2018-2023)

Table 26 South America Oxycodone Drug Revenue (USD Million) By Type (2018-2023)

Table 27 South America Oxycodone Drug Revenue (USD Million) By Applications (2018-2023)

Table 28 Middle East and Africa Oxycodone Drug Revenue (USD Million) By Region (2018-2023)

Table 29 Middle East and Africa Oxycodone Drug Revenue (USD Million) By Type (2018-2023)

Table 30 Middle East and Africa Oxycodone Drug Revenue (USD Million) By Applications (2018-2023)

Table 31 Financial Analysis

Table 32 Global Oxycodone Drug Revenue (USD Million) By Type (2024-2032)

Table 33 Global Oxycodone Drug Revenue Market Share (%) By Type (2024-2032)

Table 34 Global Oxycodone Drug Revenue (USD Million) By Applications (2024-2032)

Table 35 Global Oxycodone Drug Revenue Market Share (%) By Applications (2024-2032)

Table 36 Global Oxycodone Drug Market Revenue (USD Million), And Revenue (USD Million) By Regions (2024-2032)

Table 37 North America Oxycodone Drug Revenue (USD)By Country (2024-2032)

Table 38 North America Oxycodone Drug Revenue (USD Million) By Type (2024-2032)

Table 39 North America Oxycodone Drug Revenue (USD Million) By Applications (2024-2032)

Table 40 Europe Oxycodone Drug Revenue (USD Million) By Country (2024-2032)

Table 41 Europe Oxycodone Drug Revenue (USD Million) By Type (2024-2032)

Table 42 Europe Oxycodone Drug Revenue (USD Million) By Applications (2024-2032)

Table 43 Asia Pacific Oxycodone Drug Revenue (USD Million) By Country (2024-2032)

Table 44 Asia Pacific Oxycodone Drug Revenue (USD Million) By Type (2024-2032)

Table 45 Asia Pacific Oxycodone Drug Revenue (USD Million) By Applications (2024-2032)

Table 46 South America Oxycodone Drug Revenue (USD Million) By Country (2024-2032)

Table 47 South America Oxycodone Drug Revenue (USD Million) By Type (2024-2032)

Table 48 South America Oxycodone Drug Revenue (USD Million) By Applications (2024-2032)

Table 49 Middle East and Africa Oxycodone Drug Revenue (USD Million) By Region (2024-2032)

Table 50 Middle East and Africa Oxycodone Drug Revenue (USD Million) By Region (2024-2032)

Table 51 Middle East and Africa Oxycodone Drug Revenue (USD Million) By Type (2024-2032)

Table 52 Middle East and Africa Oxycodone Drug Revenue (USD Million) By Applications (2024-2032)

Table 53 Research Programs/Design for This Report

Table 54 Key Data Information from Secondary Sources

Table 55 Key Data Information from Primary Sources

 

List of Figures

Figure 1 Market Scope

Figure 2 Porter’s Five Forces

Figure 3 Global Oxycodone Drug Revenue (USD Million) By Type (2018-2023)

Figure 4 Global Oxycodone Drug Revenue Market Share (%) By Type (2023)

Figure 5 Global Oxycodone Drug Revenue (USD Million) By Applications (2018-2023)

Figure 6 Global Oxycodone Drug Revenue Market Share (%) By Applications (2023)

Figure 7 Global Oxycodone Drug Market Revenue (USD Million) By Regions (2018-2023)

Figure 8 Global Oxycodone Drug Market Share (%) By Regions (2023)

Figure 9 North America Oxycodone Drug Revenue (USD Million) By Country (2018-2023)

Figure 10 North America Oxycodone Drug Revenue (USD Million) By Type (2018-2023)

Figure 11 North America Oxycodone Drug Revenue (USD Million) By Applications (2018-2023)

Figure 12 Europe Oxycodone Drug Revenue (USD Million) By Country (2018-2023)

Figure 13 Europe Oxycodone Drug Revenue (USD Million) By Type (2018-2023)

Figure 14 Europe Oxycodone Drug Revenue (USD Million) By Applications (2018-2023)

Figure 15 Asia Pacific Oxycodone Drug Revenue (USD Million) By Country (2018-2023)

Figure 16 Asia Pacific Oxycodone Drug Revenue (USD Million) By Type (2018-2023)

Figure 17 Asia Pacific Oxycodone Drug Revenue (USD Million) By Applications (2018-2023)

Figure 18 South America Oxycodone Drug Revenue (USD Million) By Country (2018-2023)

Figure 19 South America Oxycodone Drug Revenue (USD Million) By Type (2018-2023)

Figure 20 South America Oxycodone Drug Revenue (USD Million) By Applications (2018-2023)

Figure 21 Middle East and Africa Oxycodone Drug Revenue (USD Million) By Region (2018-2023)

Figure 22 Middle East and Africa Oxycodone Drug Revenue (USD Million) By Type (2018-2023)

Figure 23 Middle East and Africa Oxycodone Drug Revenue (USD Million) By Applications (2018-2023)

Figure 24 Global Oxycodone Drug Revenue (USD Million) By Type (2024-2032)

Figure 25 Global Oxycodone Drug Revenue Market Share (%) By Type (2030)

Figure 26 Global Oxycodone Drug Revenue (USD Million) By Applications (2024-2032)

Figure 27 Global Oxycodone Drug Revenue Market Share (%) By Applications (2030)

Figure 28 Global Oxycodone Drug Market Revenue (USD Million) By Regions (2024-2032)

Figure 29 North America Oxycodone Drug Revenue (USD Million) By Country (2024-2032)

Figure 30 North America Oxycodone Drug Revenue (USD Million) By Type (2024-2032)

Figure 31 North America Oxycodone Drug Revenue (USD Million) By Applications (2024-2032)

Figure 32 Europe Oxycodone Drug Revenue (USD Million) By Country (2024-2032)

Figure 33 Europe Oxycodone Drug Revenue (USD Million) By Type (2024-2032)

Figure 34 Europe Oxycodone Drug Revenue (USD Million) By Applications (2024-2032)

Figure 35 Asia Pacific Oxycodone Drug Revenue (USD Million) By Country (2024-2032)

Figure 36 Asia Pacific Oxycodone Drug Revenue (USD Million) By Type (2024-2032)

Figure 37 Asia Pacific Oxycodone Drug Revenue (USD Million) By Applications (2024-2032)

Figure 38 South America Oxycodone Drug Revenue (USD Million) By Country (2024-2032)

Figure 39 South America Oxycodone Drug Revenue (USD Million) By Type (2024-2032)

Figure 40 South America Oxycodone Drug Revenue (USD Million) By Applications (2024-2032)

Figure 41 Middle East and Africa Oxycodone Drug Revenue (USD Million) By Region (2024-2032)

Figure 42 Middle East and Africa Oxycodone Drug Revenue (USD Million) By Region (2024-2032)

Figure 43 Middle East and Africa Oxycodone Drug Revenue (USD Million) By Type (2024-2032)

Figure 44 Middle East and Africa Oxycodone Drug Revenue (USD Million) By Applications (2024-2032)

Figure 45 Bottom-Up and Top-Down Approaches for This Report

Figure 46 Data Triangulation

Oxycodone Drug Market Segmentation

By Product Type

• Short-acting
• Long-acting

 

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

 

By Region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)